Global Montelukast Sodium Market Growth 2025-2031
Description
The global Montelukast Sodium market size is predicted to grow from US$ 479 million in 2025 to US$ 1023 million in 2031; it is expected to grow at a CAGR of 13.5% from 2025 to 2031.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
The Montelukast Sodium market is experiencing significant growth, driven by the increasing global prevalence of respiratory conditions such as asthma and allergic rhinitis. As a leukotriene receptor antagonist, Montelukast Sodium effectively reduces inflammation and bronchoconstriction, making it a preferred treatment option. The market's expansion is further supported by the rising geriatric population, heightened awareness of respiratory health, and the affordability of generic alternatives following patent expirations. Additionally, the development of combination therapies and advancements in drug formulations are enhancing treatment efficacy and patient compliance. The COVID-19 pandemic also underscored the importance of respiratory medications, with studies suggesting Montelukast's potential in mitigating certain viral effects, thereby boosting its demand.
Regionally, North America holds a substantial share of the Montelukast Sodium market, attributed to its advanced healthcare infrastructure and high incidence of asthma. However, the Asia-Pacific region is projected to witness the fastest growth, fueled by increasing healthcare investments, urbanization, and a growing patient population. Despite the positive outlook, the market faces challenges such as pricing pressures from generic competition, potential side effects, and the emergence of alternative therapies. Nonetheless, ongoing research and development, coupled with strategic collaborations among pharmaceutical companies, are expected to sustain the market's upward trajectory.
LP Information, Inc. (LPI) ' newest research report, the “Montelukast Sodium Industry Forecast” looks at past sales and reviews total world Montelukast Sodium sales in 2024, providing a comprehensive analysis by region and market sector of projected Montelukast Sodium sales for 2025 through 2031. With Montelukast Sodium sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Montelukast Sodium industry.
This Insight Report provides a comprehensive analysis of the global Montelukast Sodium landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Montelukast Sodium portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Montelukast Sodium market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Montelukast Sodium and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Montelukast Sodium.
This report presents a comprehensive overview, market shares, and growth opportunities of Montelukast Sodium market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Montelukast Sodium Amorphous
Montelukast Sodium Crystalline
Segmentation by Application:
Tablets
Chewable Tablet
Oral Solution
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Morepen Laboratories
Mylan
TAPI
Ultratech India
Aurobindo Pharma
Hetero Labs
Unimark Remedies
Ortin Laboratories
Vamsi Labs
Adley Group
Arromax Pharmaceutical Technology
Lunan
Dongyue
Anxin
Key Questions Addressed in this Report
What is the 10-year outlook for the global Montelukast Sodium market?
What factors are driving Montelukast Sodium market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Montelukast Sodium market opportunities vary by end market size?
How does Montelukast Sodium break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
The impact of the latest U.S. tariff measures and the corresponding policy responses from countries worldwide on market competitiveness, regional economic performance, and supply chain configurations will be comprehensively evaluated in this report.
Montelukast sodium is a hygroscopic, optically active, and white to off-white powder. Montelukast sodium is freely soluble in ethanol, methanol, and water and practically insoluble in acetonitrile. It is administered orally for prophylaxis and chronic treatment of asthma, exercise-induced bronchoconstriction, and allergic rhinitis.
The Montelukast Sodium market is experiencing significant growth, driven by the increasing global prevalence of respiratory conditions such as asthma and allergic rhinitis. As a leukotriene receptor antagonist, Montelukast Sodium effectively reduces inflammation and bronchoconstriction, making it a preferred treatment option. The market's expansion is further supported by the rising geriatric population, heightened awareness of respiratory health, and the affordability of generic alternatives following patent expirations. Additionally, the development of combination therapies and advancements in drug formulations are enhancing treatment efficacy and patient compliance. The COVID-19 pandemic also underscored the importance of respiratory medications, with studies suggesting Montelukast's potential in mitigating certain viral effects, thereby boosting its demand.
Regionally, North America holds a substantial share of the Montelukast Sodium market, attributed to its advanced healthcare infrastructure and high incidence of asthma. However, the Asia-Pacific region is projected to witness the fastest growth, fueled by increasing healthcare investments, urbanization, and a growing patient population. Despite the positive outlook, the market faces challenges such as pricing pressures from generic competition, potential side effects, and the emergence of alternative therapies. Nonetheless, ongoing research and development, coupled with strategic collaborations among pharmaceutical companies, are expected to sustain the market's upward trajectory.
LP Information, Inc. (LPI) ' newest research report, the “Montelukast Sodium Industry Forecast” looks at past sales and reviews total world Montelukast Sodium sales in 2024, providing a comprehensive analysis by region and market sector of projected Montelukast Sodium sales for 2025 through 2031. With Montelukast Sodium sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Montelukast Sodium industry.
This Insight Report provides a comprehensive analysis of the global Montelukast Sodium landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on Montelukast Sodium portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Montelukast Sodium market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Montelukast Sodium and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Montelukast Sodium.
This report presents a comprehensive overview, market shares, and growth opportunities of Montelukast Sodium market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
Montelukast Sodium Amorphous
Montelukast Sodium Crystalline
Segmentation by Application:
Tablets
Chewable Tablet
Oral Solution
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Morepen Laboratories
Mylan
TAPI
Ultratech India
Aurobindo Pharma
Hetero Labs
Unimark Remedies
Ortin Laboratories
Vamsi Labs
Adley Group
Arromax Pharmaceutical Technology
Lunan
Dongyue
Anxin
Key Questions Addressed in this Report
What is the 10-year outlook for the global Montelukast Sodium market?
What factors are driving Montelukast Sodium market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do Montelukast Sodium market opportunities vary by end market size?
How does Montelukast Sodium break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
116 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for Montelukast Sodium by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for Montelukast Sodium by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
